-
公开(公告)号:US07160915B2
公开(公告)日:2007-01-09
申请号:US10897464
申请日:2004-07-22
申请人: Stephen Douglas Barrett , Cathlin Marie Flamme , Michael David Kaufman , Jared Bruce John Milbank , Haile Tecle , Joseph Scott Warmus
发明人: Stephen Douglas Barrett , Cathlin Marie Flamme , Michael David Kaufman , Jared Bruce John Milbank , Haile Tecle , Joseph Scott Warmus
IPC分类号: A61K31/4184 , C07D235/22 , C07D235/06
CPC分类号: C07D235/06 , C07D235/14 , C07D403/06 , C07D403/12 , C07D405/12 , C07D413/04
摘要: The present invention relates to N-methyl-substituted benzamidazole derivatives of formula (I): as defined in the specification; pharmaceutical compositions and methods of use thereof.
摘要翻译: 本发明涉及式(I)的N-甲基取代的苯甲胺唑衍生物:如说明书中所定义; 药物组合物及其使用方法。
-
2.
公开(公告)号:US07078438B2
公开(公告)日:2006-07-18
申请号:US11051142
申请日:2005-02-04
申请人: Gordon William Rewcastle , Julie Ann Spicer , Stephen Douglas Barrett , Michael David Kaufman , Jared Bruce John Milbank , Haile Tecle
发明人: Gordon William Rewcastle , Julie Ann Spicer , Stephen Douglas Barrett , Michael David Kaufman , Jared Bruce John Milbank , Haile Tecle
IPC分类号: A61K31/165
CPC分类号: C07C317/36 , C07C259/10 , C07C323/36 , Y10S514/825
摘要: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
摘要翻译: 本发明涉及4-取代苯基氨基苯并肟酸衍生物的氧化酯,药物组合物及其使用方法。
-
3.
公开(公告)号:US06891066B2
公开(公告)日:2005-05-10
申请号:US10349801
申请日:2003-01-23
申请人: Gordon William Rewcastle , Julie Ann Spicer , Stephen Douglas Barrett , Michael David Kaufman , Jared Bruce John Milbank , Haile Tecle
发明人: Gordon William Rewcastle , Julie Ann Spicer , Stephen Douglas Barrett , Michael David Kaufman , Jared Bruce John Milbank , Haile Tecle
IPC分类号: A61P9/04 , A61K31/165 , A61K31/166 , A61K31/18 , A61K31/21 , A61K31/27 , A61K31/66 , A61P9/10 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P35/00 , A61P43/00 , C07C229/58 , C07C233/65 , C07C237/28 , C07C259/10 , C07C311/45 , C07C317/36 , C07C323/36 , C07C323/39
CPC分类号: C07C317/36 , C07C259/10 , C07C323/36 , Y10S514/825
摘要: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
摘要翻译: 本发明涉及4-取代苯基氨基苯并肟酸衍生物的氧化酯,药物组合物及其使用方法。
-
4.
公开(公告)号:US06943183B2
公开(公告)日:2005-09-13
申请号:US10257301
申请日:2001-04-16
申请人: William Alexander Denny , Richard H. Hutchings , Douglas S. Johnson , James Stanley Kaltenbronn , Ho Huat Lee , Daniele Marie Leonard , Jared Bruce John Milbank , Joseph Thomas Repine , Gordon William Rewcastle , Andrew David White
发明人: William Alexander Denny , Richard H. Hutchings , Douglas S. Johnson , James Stanley Kaltenbronn , Ho Huat Lee , Daniele Marie Leonard , Jared Bruce John Milbank , Joseph Thomas Repine , Gordon William Rewcastle , Andrew David White
IPC分类号: C07D233/60 , A61K31/4164 , A61K31/4178 , A61K31/422 , A61K31/4439 , A61K31/4725 , A61K31/496 , A61K31/497 , A61P9/10 , A61P13/00 , A61P13/08 , A61P17/06 , A61P27/02 , A61P31/12 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/91 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/14 , C07D521/00 , C07D233/64
CPC分类号: C07D233/64 , C07D231/12 , C07D233/56 , C07D233/91 , C07D249/08 , C07D401/12
摘要: The present invention provides novel 5-substituted tetralones of Formulas I, II, III, and IV and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme
摘要翻译: 本发明提供式I,II,III和IV的新型5-取代四氢萘酮及其药学上可接受的盐,酯,酰胺和前药,其可用于治疗和预防组织如癌症的不受控制或异常增殖, 动脉粥样硬化,再狭窄和牛皮癣。 具体地,本发明涉及抑制法呢基转移酶的化合物
-
公开(公告)号:US20110112100A1
公开(公告)日:2011-05-12
申请号:US12868342
申请日:2010-08-25
IPC分类号: A61K31/498 , C07D241/36 , A61P31/14
CPC分类号: C07D403/14 , C07D401/14 , C07D403/04 , C07F5/025 , C07F7/0812
摘要: The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HCV replication.
摘要翻译: 本发明涉及含有这些化合物的组合物以及使用这些化合物作为HCV复制抑制剂的式(I)化合物及其药学上可接受的盐。
-
-
-
-